Obesity and Falls in a Prospective Study of Older Men: The Osteoporotic Fractures in Men Study

Elizabeth R Hooker1, Smriti Shrestha1,2, Christine G Lee3

  • 11 Oregon Health & Science University, Portland, USA.

Abstract

Insights

Older, obese men aged 65-80 experience significantly higher fall rates. Dynamic balance, measured by narrow walk time, appears to be a key factor influencing this association.

Area of Science:

  • Gerontology
  • Biomedical Engineering
  • Epidemiology

Background:

  • Falls are a major health concern for older adults, leading to fractures and reduced mobility.
  • Body Mass Index (BMI) and age are known risk factors for falls, but their interplay requires further investigation.
  • Physical performance, including gait stability, may mediate the relationship between BMI and fall risk.

Purpose of the Study:

  • To investigate the association between Body Mass Index (BMI) categories and fall rates in older men.
  • To examine how age modifies the relationship between BMI and fall incidence.
  • To explore the role of physical performance and comorbidities in the BMI-falls relationship.

Main Methods:

  • Utilized data from the Osteoporotic Fractures in Men (MrOS) study, including 5,834 men aged 65 and older.
  • Collected fall data every 4 months over an average of 4.8 years.
  • Employed mixed-effects models to analyze adjusted associations between BMI and incident falls, considering age and physical performance metrics.

Main Results:

  • Overall fall rate was 0.66/man-year, with the lowest rates in younger, normal-weight men (0.44/man-year) and highest in older, high-BMI men (1.47/man-year).
  • Obesity was linked to a 24%-92% increased fall risk in men under 80 (p-trend ≤ .0001).
  • The association between BMI and falls was substantially altered only after adjusting for dynamic balance tests (narrow walk time).

Conclusions:

  • Obesity is an independent risk factor for increased fall rates in men aged 65 to 80.
  • Gait stability, as indicated by narrow walk time, may play a mediating role in the association between obesity and falls in older men.
  • These findings highlight the importance of assessing physical performance in fall prevention strategies for older adults, particularly those with higher BMI.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
330
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
351
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
267
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
309
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
344